The effect of co-expression of a 3111 tetramer with various N-terminal deletions or chimeras of Orai1/Orai3 monomers on store-operated and arachidonic acid activated currents. (A) Diagrams illustrating the basic composition of the various N-terminally modified Orai1/Orai3 monomers examined. Again, components from Orai1 are represented in grey, whilst those from Orai3 are in black. (B) Inward currents measured at −40 mV recorded in STIM1-stable cells on expression of the 3111 tetramer with the various N-terminally modified Orai1/Orai3 monomers indicated in (A) above. Other information as in Figure 2. For comparative purposes, the corresponding values recorded on expression of the 3111 tetramer alone, and 3111 tetramer co-expressed with the either intact Orai3 monomer or the intact Orai1 monomer are also shown (data taken from Fig. 2). Values are means ± SEM, with values of n for store-operated and arachidonic acid activated equal to 6 and 5 (tetramer plus [X11]), 7 and 5 (tetramer plus [X33]), 6 and 6 (tetramer plus [(1/3)11]), and 8 and 6 (tetramer plus [(3/1)11]), respectively. (C) Representative curves of the current-voltage relationship for the store-operated current (grey) and the arachidonic acid activated current (black) seen on co-expression of the 3111 tetramer with either the N-terminally-deleted Orai1 monomer [X11] (top left), or the corresponding N-terminally-deleted Orai3 monomer [X33] (top right), and the N-terminal chimeric monomers, [(1/3)11] (bottom left), and [(3/1)11] (bottom right).